Pegargiminase Completed Phase 2 Trials for Melanoma (Skin) / Malignant Melanoma of Skin Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00450372Pegylated Arginine Deiminase in Treating Patients With Metastatic Melanoma That Cannot Be Removed by Surgery